We are pleased to announce that the 4th Metronomic Chemotherapy Meeting will take place in Milano on the 24-25th June in the IFOM-IEO Campus, Milano, Italy. The organisator is Pr Francesco Bertolini, Director of the Laboratory of Hematology/Oncology at the European Institute of Oncology in Milan and the Chairs and organizing committee will be composed of Francesco Bertolini, Marco Colleoni, Saverio Cinieri, Nicolas André and Yuval Shaked. A specific website has been set for this event, where registration will be opened soon. The program of the meeting will include preclinical, adult and pediatric oncology, low income country sessions.
The First Barton Kamen Prize will also be given during the meeting. To learn more about it click here
Abstract can be sumitted directly to francesco.bertolini@ieo.it. Full instructions for the abstract can be found here
New information such as dates, expected speakers, preliminary program will be regularly posted.
FINAL PROGRAM
June 24th
12.50-13.00 F. Bertolini - Welcome and introduction
session 1: The landscape of the field.
Chair: F. Bertolini and L. Hutchinson
13.00-13.30 R. S. Kerbel : Metronomic from 2000 to 2014
13.30-14.00 Y. Shaked - Preclinical new hypotheses
14.00-14.30 L. Hutchinson, editor of “Nature Reviews in Clinical Oncology”: Metronomic needs from the perspective of an editor
Session 2: breast cancer, pediatric cancer and models.
Chairs: M. Colleoni and N. Andrè
14.30-15.00 M. Colleoni - Clinical Overview on the metronomic experience in breast cancer
15.00-15.30 E. Munzone: Present and future trials in breast cancer
15.30-16.00 G. Curigliano: Metronomic chemotherapy for lymphangitic breast cancer
16.00-16.30 coffee break
16.30-17.00 G. Brandi – Metronomic chemotherapy for hepatocellular carcinomas
17.00-18.00 F. Berthold and J. Sterba : Pediatric metronomic therapy
18.00-18.30 U. Ledzewicz: Mathematical models for chemotherapy
18.30-19.00 Ugo Cavallaro: New Players and targets in Tumor Vasculature
19.00-19.30 Barton Kamen-MGHI Prize
June 25th
session 3: Biomarkers and repositioning.
Chair R. S. Kerbel and Y. Shaked
09.00-9.30 G. Bocci - Biomarkers for Metronomic chemotherapy
09.30-11.00 N. André-A.Eniu-S.Banavali - Metronomics and low/middle income countries
11.00 - 11.30 coffee break
11.30-12.00 E. Pasquier : Is drug repositioning metronomic?
12.00-12.30 F. Bertolini: Repositioning: Metronomic therapy beyond metronomic chemotherapy
12.30-13.30 Lunch
Session 4: More types of cancer and selected presentations.
Chair: S. Cinieri and S.Banavali
13.30-14.00 M. Villalba: tailored metronomic approaches for acute leukemia
14.00-14.40 N. Fazio and A. Berruti: Metronomic chemotherapy for endocrine and neuroendocrine tumors
14.40-17.00 Oral presentation session with 7 talks 15 5 min
17.00-17:30 Round table: where do we go from here. Questions and answers R.S. Kerbel, F. Bertolini, M. Colleoni, S. Cinieri, N. Andrè, Y. Shaked. S. Banavali
17.30: Concluding remarks
